PMID- 23712032 OWN - NLM STAT- MEDLINE DCOM- 20140303 LR - 20171116 IS - 1873-3913 (Electronic) IS - 0898-6568 (Linking) VI - 25 IP - 10 DP - 2013 Oct TI - Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. PG - 1993-2002 LID - S0898-6568(13)00157-5 [pii] LID - 10.1016/j.cellsig.2013.05.026 [doi] AB - Here we report that activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in both primary cultured human colon cancer cells and cell lines. Knocking-down of AMPKalpha by the target shRNA significantly inhibits plumbagin-induced cytotoxicity in cultured colon cancer cells, while forced activation of AMPK by introducing a constitutively active AMPK (CA-AMPK), or by the AMPK activator, inhibits HT-29 colon cancer cell growth. Our Western-blots and immunoprecipitation (IP) results demonstrate that plumbagin induces AMPK/Apoptosis signal regulating kinase 1 (ASK1)/TNF receptor-associated factor 2 (TRAF2) association to activate pro-apoptotic c-Jun N-terminal kinases (JNK)-p53 signal axis. Further, after plumbagin treatment, activated AMPK directly phosphorylates Raptor to inhibit mTOR complex 1 (mTORC1) activation and Bcl-2 expression in colon cancer cells. Finally, we found that exogenously-added short-chain ceramide (C6) enhances plumbagin-induced AMPK activation and facilitates cell apoptosis and growth inhibition. Our results suggest that AMPK might be the key mediator of plumbagin's anti-tumor activity. CI - Copyright (c) 2013. Published by Elsevier Inc. FAU - Chen, Min-Bin AU - Chen MB AD - Department of Medical Oncology, Kunshan First People's Hospital Affiliated to Jiangsu University, 91 Qianjin Road, Kunshan 215300, Jiangsu Province, China. FAU - Zhang, Yan AU - Zhang Y FAU - Wei, Mu-Xin AU - Wei MX FAU - Shen, Wei AU - Shen W FAU - Wu, Xiao-Yang AU - Wu XY FAU - Yao, Chen AU - Yao C FAU - Lu, Pei-Hua AU - Lu PH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130525 PL - England TA - Cell Signal JT - Cellular signalling JID - 8904683 RN - 0 (Antineoplastic Agents, Phytogenic) RN - 0 (Naphthoquinones) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - YAS4TBQ4OQ (plumbagin) SB - IM MH - AMP-Activated Protein Kinases/antagonists & inhibitors/genetics/*metabolism MH - Antineoplastic Agents, Phytogenic MH - Apoptosis/*genetics MH - Cell Line, Tumor MH - Cell Proliferation MH - Colonic Neoplasms/genetics/*metabolism/pathology MH - Gene Expression Regulation, Neoplastic MH - HT29 Cells MH - Humans MH - Naphthoquinones/metabolism MH - Phosphorylation MH - Primary Cell Culture MH - Reactive Oxygen Species/*metabolism MH - Signal Transduction/genetics OTO - NOTNLM OT - 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside OT - ACC OT - AICAR OT - AMP-activated protein kinase OT - AMP-activated protein kinase (AMPK) OT - AMPK OT - ASK1 OT - Colon cancer OT - FACS OT - IP OT - JNK OT - NAC OT - PI OT - Plumbagin OT - RNA interference OT - RNAi OT - ROS OT - Raptor OT - S6K1 OT - TNF receptor-associated factor 2 OT - TRAF2 OT - TSC2 OT - UA OT - acetyl-CoA carboxylase OT - apoptosis signal regulating kinase 1 OT - c-Jun N-terminal kinase OT - fluorescence-activated cell sorting OT - immunoprecipitation OT - mTOR complex 1 OT - mTORC1 OT - n-acetyl-l-cysteine OT - propidium iodide OT - reactive oxygen species OT - regulatory associated protein of mTOR OT - ribosomal p70 S6 kinase OT - tuberous sclerosis protein 2 OT - ursolic acid EDAT- 2013/05/29 06:00 MHDA- 2014/03/04 06:00 CRDT- 2013/05/29 06:00 PHST- 2013/03/21 00:00 [received] PHST- 2013/05/18 00:00 [accepted] PHST- 2013/05/29 06:00 [entrez] PHST- 2013/05/29 06:00 [pubmed] PHST- 2014/03/04 06:00 [medline] AID - S0898-6568(13)00157-5 [pii] AID - 10.1016/j.cellsig.2013.05.026 [doi] PST - ppublish SO - Cell Signal. 2013 Oct;25(10):1993-2002. doi: 10.1016/j.cellsig.2013.05.026. Epub 2013 May 25.